Skip to main content
. Author manuscript; available in PMC: 2014 Mar 3.
Published in final edited form as: Psychopharmacology (Berl). 2011 Sep 24;220(2):367–378. doi: 10.1007/s00213-011-2483-1

Table 1.

Subjects, sample sizes, and sample losses across experiments

Expt # Subjects Initial N Final N # Groups Final N/Group Subject Loss

Death/Illness Other
1 WSC-2  71 64  4 14–19  5  2
2 WSC-1 & WSC-2 111  87  4 18–22  3 21
3 WSC-2 194 160 14 9–13 26  8
4 WSC-2  60  45  4 8–15  6  9
5 WSC-2  22  19  2 9–10  0  3
6 WSC-1  44  34  2 5–17  2  8
7 WSC-2  40  34  2 16–18  2  4
8 WSP & WSR 152  94  8 8–17 41 17